MAO-B-IN-49

MAO-B-IN-49 is a selective, reversible MAO-B inhibitor with an IC50 of 1 nM for human MAO-B. It demonstrates significantly higher selectivity for MAO-B over MAO-A (IC50 = 633.9 nM) . MAO-B-IN-49 reduces lipopolysaccharide (LPS) -induced ROS production in HT22 cells. It possesses notable neuroprotective properties and significantly improves motor dysfunction in MPTP-induced Parkinson's disease (PD) mouse models. MAO-B-IN-49 is applicable for Parkinson's disease research.